» Articles » PMID: 27533040

Tumour Hypoxia Causes DNA Hypermethylation by Reducing TET Activity

Abstract

Hypermethylation of the promoters of tumour suppressor genes represses transcription of these genes, conferring growth advantages to cancer cells. How these changes arise is poorly understood. Here we show that the activity of oxygen-dependent ten-eleven translocation (TET) enzymes is reduced by tumour hypoxia in human and mouse cells. TET enzymes catalyse DNA demethylation through 5-methylcytosine oxidation. This reduction in activity occurs independently of hypoxia-associated alterations in TET expression, proliferation, metabolism, hypoxia-inducible factor activity or reactive oxygen species, and depends directly on oxygen shortage. Hypoxia-induced loss of TET activity increases hypermethylation at gene promoters in vitro. In patients, tumour suppressor gene promoters are markedly more methylated in hypoxic tumour tissue, independent of proliferation, stromal cell infiltration and tumour characteristics. Our data suggest that up to half of hypermethylation events are due to hypoxia, with these events conferring a selective advantage. Accordingly, increased hypoxia in mouse breast tumours increases hypermethylation, while restoration of tumour oxygenation abrogates this effect. Tumour hypoxia therefore acts as a novel regulator of DNA methylation.

Citing Articles

Aberrant DNA methylation as a key modulator of cell death pathways: insights into cancer progression and other diseases.

Zahoor A, Khazer R, Mehraj I, Gani U, Fayaz F, Khanday F Funct Integr Genomics. 2025; 25(1):50.

PMID: 40024973 DOI: 10.1007/s10142-025-01552-x.


Hypoxia-induced ATF3 escalates breast cancer invasion by increasing collagen deposition via P4HA1.

Dhamdhere S, Bansal A, Singh P, Kakani P, Agrawal S, Samaiya A Cell Death Dis. 2025; 16(1):142.

PMID: 40016181 PMC: 11868403. DOI: 10.1038/s41419-025-07461-y.


TET-mediated 5hmC in breast cancer: mechanism and clinical potential.

Zhang J, Aishan N, Zheng Z, Ju S, He Q, Meng Q Epigenetics. 2025; 20(1):2473250.

PMID: 40014756 PMC: 11869774. DOI: 10.1080/15592294.2025.2473250.


Tumor microenvironment-responsive and modulatory manganese-based nanoenzyme for enhanced tumor immunotherapy.

Yang Q, Wu Q, Liu H, Wu J, Ma F, Tian X Front Pharmacol. 2025; 15():1518983.

PMID: 39830353 PMC: 11739168. DOI: 10.3389/fphar.2024.1518983.


Gene expression and DNA methylation changes in response to hypoxia in toxicant-adapted Atlantic killifish (Fundulus heteroclitus).

Aluru N, Venkataraman Y, Murray C, DePascuale V Biol Open. 2025; 14(1.

PMID: 39760289 PMC: 11744052. DOI: 10.1242/bio.061801.


References
1.
Kuchnio A, Moens S, Bruning U, Kuchnio K, Cruys B, Thienpont B . The Cancer Cell Oxygen Sensor PHD2 Promotes Metastasis via Activation of Cancer-Associated Fibroblasts. Cell Rep. 2015; 12(6):992-1005. DOI: 10.1016/j.celrep.2015.07.010. View

2.
Lippert A, Van de Bittner G, Chang C . Boronate oxidation as a bioorthogonal reaction approach for studying the chemistry of hydrogen peroxide in living systems. Acc Chem Res. 2011; 44(9):793-804. PMC: 3178007. DOI: 10.1021/ar200126t. View

3.
Blaschke K, Ebata K, Karimi M, Zepeda-Martinez J, Goyal P, Mahapatra S . Vitamin C induces Tet-dependent DNA demethylation and a blastocyst-like state in ES cells. Nature. 2013; 500(7461):222-6. PMC: 3893718. DOI: 10.1038/nature12362. View

4.
Xu W, Yang H, Liu Y, Yang Y, Wang P, Kim S . Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases. Cancer Cell. 2011; 19(1):17-30. PMC: 3229304. DOI: 10.1016/j.ccr.2010.12.014. View

5.
Pelicano H, Carney D, Huang P . ROS stress in cancer cells and therapeutic implications. Drug Resist Updat. 2004; 7(2):97-110. DOI: 10.1016/j.drup.2004.01.004. View